WVU in the News: Clinical trial tests implant that offers hope to cancer patients with grim prognosis

Pancreatic cancer has almost no early symptoms, so by the time it’s caught it’s often advanced and has sometimes spread. The WVU Cancer Institute is helping lead a global first in pancreatic cancer research with the launch of a first-in-human clinical trial testing a small implant designed to deliver chemotherapy directly into pancreatic tumors.

Brian Boone, M.D., associate professor of surgical oncology at the WVU Department of Surgery and principal investigator of the study, explained how the investigational device could potentially overcome one of the biggest challenges in pancreatic cancer treatment: getting chemotherapy to actually penetrate the tumor. Boone said the new technique could sharply improve survival rates.

Related Stories

New Pancreatic Cancer Trial Tests Implant That Delivers Chemotherapy Directly to Tumors - Cure

Clinical Trial Offers Hope To Cancer Patients With Grim Prognosis - WV Public Broadcasting